Published in Semin Radiat Oncol on April 01, 2011
A method for estimating the oxygen consumption rate in multicellular tumour spheroids. J R Soc Interface (2014) 1.25
Oxygen consumption dynamics in steady-state tumour models. R Soc Open Sci (2014) 0.90
Estimating oxygen distribution from vasculature in three-dimensional tumour tissue. J R Soc Interface (2016) 0.79
Functional lung avoidance and response-adaptive escalation (FLARE) RT: multimodality plan dosimetry of a precision radiation oncology strategy. Med Phys (2017) 0.75
Consensus recommendations for the use of 18F-FDG PET as an indicator of therapeutic response in patients in National Cancer Institute Trials. J Nucl Med (2006) 7.40
Partial-volume effect in PET tumor imaging. J Nucl Med (2007) 5.81
Standards for PET image acquisition and quantitative data analysis. J Nucl Med (2009) 4.37
Comparison of different methods for delineation of 18F-FDG PET-positive tissue for target volume definition in radiotherapy of patients with non-Small cell lung cancer. J Nucl Med (2005) 3.26
[18F]fluoro-deoxy-glucose positron emission tomography ([18F]FDG-PET) voxel intensity-based intensity-modulated radiation therapy (IMRT) for head and neck cancer. Radiother Oncol (2006) 2.22
Use of PET and PET/CT for radiation therapy planning: IAEA expert report 2006-2007. Radiother Oncol (2008) 2.07
Accurate automatic delineation of heterogeneous functional volumes in positron emission tomography for oncology applications. Int J Radiat Oncol Biol Phys (2010) 1.66
Using fluorodeoxyglucose positron emission tomography to assess tumor volume during radiotherapy for non-small-cell lung cancer and its potential impact on adaptive dose escalation and normal tissue sparing. Int J Radiat Oncol Biol Phys (2009) 1.64
Image registration and data fusion in radiation therapy. Br J Radiol (2006) 1.62
A pilot study of [18F]fluorodeoxyglucose positron emission tomography scans during and after radiation-based therapy in patients with non small-cell lung cancer. J Clin Oncol (2007) 1.55
18F-FDG PET/CT for image-guided and intensity-modulated radiotherapy. J Nucl Med (2009) 1.53
Hypoxia dose painting by numbers: a planning study. Int J Radiat Oncol Biol Phys (2007) 1.51
Fluorine-18-labeled fluoromisonidazole positron emission and computed tomography-guided intensity-modulated radiotherapy for head and neck cancer: a feasibility study. Int J Radiat Oncol Biol Phys (2007) 1.50
PET-based treatment planning in radiotherapy: a new standard? J Nucl Med (2007) 1.42
Reduction of normal lung irradiation in locally advanced non-small-cell lung cancer patients, using ventilation images for functional avoidance. Int J Radiat Oncol Biol Phys (2007) 1.42
Dose escalation in non-small-cell lung cancer using three-dimensional conformal radiation therapy: update of a phase I trial. J Clin Oncol (2001) 1.37
Positron emission tomography for radiation treatment planning. Strahlenther Onkol (2005) 1.33
New developments in MRI for target volume delineation in radiotherapy. Br J Radiol (2006) 1.27
Adaptive radiotherapy for lung cancer. Semin Radiat Oncol (2010) 1.26
Early prediction of outcome in advanced head-and-neck cancer based on tumor blood volume alterations during therapy: a prospective study. Int J Radiat Oncol Biol Phys (2008) 1.24
A methodology for using SPECT to reduce intensity-modulated radiation therapy (IMRT) dose to functioning lung. Int J Radiat Oncol Biol Phys (2006) 1.24
Imaging as a Biomarker: Standards for Change Measurements in Therapy workshop summary. Acad Radiol (2008) 1.22
Optimizing radiation treatment plans for lung cancer using lung perfusion information. Radiother Oncol (2002) 1.22
Imaging cellular proliferation during chemo-radiotherapy: a pilot study of serial 18F-FLT positron emission tomography/computed tomography imaging for non-small-cell lung cancer. Int J Radiat Oncol Biol Phys (2009) 1.21
On biologically conformal boost dose optimization. Phys Med Biol (2003) 1.21
Risk-adaptive optimization: selective boosting of high-risk tumor subvolumes. Int J Radiat Oncol Biol Phys (2006) 1.18
MR imaging of the prostate in clinical practice. MAGMA (2008) 1.15
Adaptive biological image-guided IMRT with anatomic and functional imaging in pharyngo-laryngeal tumors: impact on target volume delineation and dose distribution using helical tomotherapy. Radiother Oncol (2007) 1.15
A potential to reduce pulmonary toxicity: the use of perfusion SPECT with IMRT for functional lung avoidance in radiotherapy of non-small cell lung cancer. Radiother Oncol (2007) 1.14
PET-CT in radiation oncology: the impact on diagnosis, treatment planning, and assessment of treatment response. Am J Clin Oncol (2008) 1.13
Preserving functional lung using perfusion imaging and intensity-modulated radiation therapy for advanced-stage non-small cell lung cancer. Int J Radiat Oncol Biol Phys (2007) 1.13
Biological imaging in radiation therapy: role of positron emission tomography. Phys Med Biol (2008) 1.07
Radiation dose prescription for non-small-cell lung cancer according to normal tissue dose constraints: an in silico clinical trial. Int J Radiat Oncol Biol Phys (2008) 1.07
Imaging for assessment of radiation-induced normal tissue effects. Int J Radiat Oncol Biol Phys (2010) 1.07
Adaptive radiotherapy: merging principle into clinical practice. Semin Radiat Oncol (2010) 1.06
Molecular PET/CT imaging-guided radiation therapy treatment planning. Acad Radiol (2009) 1.04
On the sensitivity of IMRT dose optimization to the mathematical form of a biological imaging-based prescription function. Phys Med Biol (2009) 1.04
Longitudinal changes in tumor perfusion pattern during the radiation therapy course and its clinical impact in cervical cancer. Int J Radiat Oncol Biol Phys (2009) 1.02
Additional PET/CT in week 5-6 of radiotherapy for patients with stage III non-small cell lung cancer as a means of dose escalation planning? Radiother Oncol (2008) 1.01
Treatment of intrahepatic cancers with radiation doses based on a normal tissue complication probability model. J Clin Oncol (1998) 1.01
Stability of 18F-deoxyglucose uptake locations within tumor during radiotherapy for NSCLC: a prospective study. Int J Radiat Oncol Biol Phys (2008) 0.99
Intensity modulated radiotherapy of non-small-cell lung cancer incorporating SPECT ventilation imaging. Med Phys (2010) 0.98
Clinical implications of defining the gross tumor volume with combination of CT and 18FDG-positron emission tomography in non-small-cell lung cancer. Int J Radiat Oncol Biol Phys (2006) 0.97
Towards biologically conformal radiation therapy (BCRT): selective IMRT dose escalation under the guidance of spatial biology distribution. Med Phys (2005) 0.97
Dose-escalation using intensity-modulated radiotherapy for prostate cancer--evaluation of the dose distribution with and without 18F-choline PET-CT detected simultaneous integrated boost. Radiother Oncol (2009) 0.96
Image-guided radiation therapy: from concept to practice. Semin Radiat Oncol (2007) 0.95
Biologically optimized 3-dimensional in vivo predictive assay-based radiation therapy using positron emission tomography-computerized tomography imaging. Acta Oncol (2003) 0.95
Applications of magnetic resonance spectroscopy in radiotherapy treatment planning. Br J Radiol (2006) 0.94
Choline PET based dose-painting in prostate cancer--modelling of dose effects. Radiat Oncol (2010) 0.94
Sensitivity of quantitative metrics derived from DCE MRI and a pharmacokinetic model to image quality and acquisition parameters. Acad Radiol (2010) 0.93
Impact of the type of imaging modality on target volumes delineation and dose distribution in pharyngo-laryngeal squamous cell carcinoma: comparison between pre- and per-treatment studies. Radiother Oncol (2006) 0.93
Carbon-11 acetate PET/CT based dose escalated IMRT in prostate cancer. Radiother Oncol (2009) 0.93
Tumor biology-guided radiotherapy treatment planning: gross tumor volume versus functional tumor volume. Semin Nucl Med (2008) 0.92
Feasibility and efficacy of single photon emission computed tomography-based three-dimensional conformal radiotherapy for hepatocellular carcinoma 8 cm or more with portal vein tumor thrombus in combination with transcatheter arterial chemoembolization. Int J Radiat Oncol Biol Phys (2009) 0.91
Effective avoidance of a functional spect-perfused lung using intensity modulated radiotherapy (IMRT) for non-small cell lung cancer (NSCLC): an update of a planning study. Radiother Oncol (2008) 0.91
Imaging readouts as biomarkers or surrogate parameters for the assessment of therapeutic interventions. Eur Radiol (2007) 0.90
Targeted molecular imaging in oncology: focus on radiation therapy. Semin Radiat Oncol (2008) 0.89
Strategies for biologic image-guided dose escalation: a review. Int J Radiat Oncol Biol Phys (2009) 0.89
A method for partial volume correction of PET-imaged tumor heterogeneity using expectation maximization with a spatially varying point spread function. Phys Med Biol (2010) 0.87
Complexity and accuracy of image registration methods in SPECT-guided radiation therapy. Phys Med Biol (2010) 0.86
Increased (18)F-deoxyglucose uptake in the lung during the first weeks of radiotherapy is correlated with subsequent Radiation-Induced Lung Toxicity (RILT): a prospective pilot study. Radiother Oncol (2009) 0.85
The role of functional imaging in the diagnosis and management of late normal tissue injury. Semin Radiat Oncol (2007) 0.84
Prediction of radiation-induced normal tissue complications in radiotherapy using functional image data. Phys Med Biol (2005) 0.84
A methodology for selecting the beam arrangement to reduce the intensity-modulated radiation therapy (IMRT) dose to the SPECT-defined functioning lung. Phys Med Biol (2009) 0.83
Biological image-guided radiotherapy in rectal cancer: challenges and pitfalls. Int J Radiat Oncol Biol Phys (2009) 0.83
Use of Veff and iso-NTCP in the implementation of dose escalation protocols. Int J Radiat Oncol Biol Phys (1993) 0.83
Adapting biological feedback in radiotherapy. Semin Radiat Oncol (2010) 0.83
On the impact of functional imaging accuracy on selective boosting IMRT. Phys Med (2008) 0.80
Serial FDG-PET on patients with head and neck cancer: implications for radiation therapy. Int J Radiat Biol (2009) 0.80
Magnetic resonance spectroscopy imaging (MRSI) and brain functional magnetic resonance imaging (fMRI) for radiotherapy treatment planning of glioma. Technol Cancer Res Treat (2008) 0.80
Metabolic functional imaging for tumor radiosensitivity monitoring. Crit Rev Oncol Hematol (2007) 0.78
A theoretical framework for prescribing radiotherapy dose distributions using patient-specific biological information. Med Phys (2008) 0.78
The importance of the accuracy of image registration of SPECT images for 3D targeted radionuclide therapy dosimetry. Phys Med Biol (2007) 0.77
Incorporating quantitative single photon emission computed tomography into radiation therapy treatment planning for lung cancer: impact of attenuation and scatter correction on the single photon emission computed tomography-weighted mean dose and functional lung segmentation. Int J Radiat Oncol Biol Phys (2010) 0.76
Use of normal tissue complication probability models in the clinic. Int J Radiat Oncol Biol Phys (2010) 4.33
Analysis of radiation-induced liver disease using the Lyman NTCP model. Int J Radiat Oncol Biol Phys (2002) 3.64
Final toxicity results of a radiation-dose escalation study in patients with non-small-cell lung cancer (NSCLC): predictors for radiation pneumonitis and fibrosis. Int J Radiat Oncol Biol Phys (2006) 3.40
High-dose radiation improved local tumor control and overall survival in patients with inoperable/unresectable non-small-cell lung cancer: long-term results of a radiation dose escalation study. Int J Radiat Oncol Biol Phys (2005) 3.32
Radiation dose-volume effects in the stomach and small bowel. Int J Radiat Oncol Biol Phys (2010) 2.69
Comparing different NTCP models that predict the incidence of radiation pneumonitis. Normal tissue complication probability. Int J Radiat Oncol Biol Phys (2003) 2.41
Radiation-associated liver injury. Int J Radiat Oncol Biol Phys (2010) 2.39
Quantitative Analyses of Normal Tissue Effects in the Clinic (QUANTEC): an introduction to the scientific issues. Int J Radiat Oncol Biol Phys (2010) 2.32
Phase II trial of high-dose conformal radiation therapy with concurrent hepatic artery floxuridine for unresectable intrahepatic malignancies. J Clin Oncol (2005) 2.20
Partial volume tolerance of the liver to radiation. Semin Radiat Oncol (2005) 1.85
Radiation-associated kidney injury. Int J Radiat Oncol Biol Phys (2010) 1.74
Using fluorodeoxyglucose positron emission tomography to assess tumor volume during radiotherapy for non-small-cell lung cancer and its potential impact on adaptive dose escalation and normal tissue sparing. Int J Radiat Oncol Biol Phys (2009) 1.64
Retrospective analysis of prostate cancer patients with implanted gold markers using off-line and adaptive therapy protocols. Int J Radiat Oncol Biol Phys (2005) 1.55
A pilot study of [18F]fluorodeoxyglucose positron emission tomography scans during and after radiation-based therapy in patients with non small-cell lung cancer. J Clin Oncol (2007) 1.55
The impact of dose on parotid salivary recovery in head and neck cancer patients treated with radiation therapy. Int J Radiat Oncol Biol Phys (2006) 1.52
Prospective study of inner ear radiation dose and hearing loss in head-and-neck cancer patients. Int J Radiat Oncol Biol Phys (2005) 1.49
Improving normal tissue complication probability models: the need to adopt a "data-pooling" culture. Int J Radiat Oncol Biol Phys (2010) 1.44
CT-based definition of thoracic lymph node stations: an atlas from the University of Michigan. Int J Radiat Oncol Biol Phys (2005) 1.38
Dose reconstruction in deforming lung anatomy: dose grid size effects and clinical implications. Med Phys (2005) 1.36
Chemo-IMRT of oropharyngeal cancer aiming to reduce dysphagia: swallowing organs late complication probabilities and dosimetric correlates. Int J Radiat Oncol Biol Phys (2011) 1.33
Salivary gland sparing and improved target irradiation by conformal and intensity modulated irradiation of head and neck cancer. World J Surg (2003) 1.28
Parotid gland function after radiotherapy: the combined michigan and utrecht experience. Int J Radiat Oncol Biol Phys (2010) 1.21
Methodological issues in radiation dose-volume outcome analyses: summary of a joint AAPM/NIH workshop. Med Phys (2002) 1.20
Guest editor's introduction to QUANTEC: a users guide. Int J Radiat Oncol Biol Phys (2010) 1.20
Association of 11C-methionine PET uptake with site of failure after concurrent temozolomide and radiation for primary glioblastoma multiforme. Int J Radiat Oncol Biol Phys (2008) 1.14
How extensive of a 4D dataset is needed to estimate cumulative dose distribution plan evaluation metrics in conformal lung therapy? Med Phys (2007) 1.13
Use of principal component analysis to evaluate the partial organ tolerance of normal tissues to radiation. Int J Radiat Oncol Biol Phys (2005) 1.11
Physical models and simpler dosimetric descriptors of radiation late toxicity. Semin Radiat Oncol (2007) 1.10
Liver function after irradiation based on computed tomographic portal vein perfusion imaging. Int J Radiat Oncol Biol Phys (2007) 1.08
A method for incorporating organ motion due to breathing into 3D dose calculations in the liver: sensitivity to variations in motion. Med Phys (2003) 1.08
Normal tissue complication probability modeling for acute esophagitis in patients treated with conformal radiation therapy for non-small cell lung cancer. Radiother Oncol (2005) 1.08
Imaging for assessment of radiation-induced normal tissue effects. Int J Radiat Oncol Biol Phys (2010) 1.07
Defining target volumes for non-small cell lung carcinoma. Semin Radiat Oncol (2004) 1.06
A fluence convolution method to account for respiratory motion in three-dimensional dose calculations of the liver: a Monte Carlo study. Med Phys (2003) 1.06
A comparison of dose-response models for the parotid gland in a large group of head-and-neck cancer patients. Int J Radiat Oncol Biol Phys (2009) 1.05
Concurrent temozolomide and dose-escalated intensity-modulated radiation therapy in newly diagnosed glioblastoma. Clin Cancer Res (2011) 1.05
Combining physical and biologic parameters to predict radiation-induced lung toxicity in patients with non-small-cell lung cancer treated with definitive radiation therapy. Int J Radiat Oncol Biol Phys (2012) 1.05
Synchronized dynamic dose reconstruction. Med Phys (2007) 1.03
Long-term results of high-dose conformal radiotherapy for patients with medically inoperable T1-3N0 non-small-cell lung cancer: is low incidence of regional failure due to incidental nodal irradiation? Int J Radiat Oncol Biol Phys (2005) 1.01
Alterations in normal liver doses due to organ motion. Int J Radiat Oncol Biol Phys (2003) 1.00
Prediction of liver function by using magnetic resonance-based portal venous perfusion imaging. Int J Radiat Oncol Biol Phys (2012) 0.99
A practical approach for quantitative estimates of voxel-by-voxel liver perfusion using DCE imaging and a compartmental model. Med Phys (2006) 0.98
Evaluating changes in tumor volume using magnetic resonance imaging during the course of radiotherapy treatment of high-grade gliomas: Implications for conformal dose-escalation studies. Int J Radiat Oncol Biol Phys (2005) 0.95
Multiple fields may offer better esophagus sparing without increased probability of lung toxicity in optimized IMRT of lung tumors. Int J Radiat Oncol Biol Phys (2006) 0.95
Metabolic Tumor Volume on PET Reduced More than Gross Tumor Volume on CT during Radiotherapy in Patients with Non-Small Cell Lung Cancer Treated with 3DCRT or SBRT. J Radiat Oncol (2013) 0.93
Results following treatment to doses of 92.4 or 102.9 Gy on a phase I dose escalation study for non-small cell lung cancer. Lung Cancer (2004) 0.92
Benefit of using biologic parameters (EUD and NTCP) in IMRT optimization for treatment of intrahepatic tumors. Int J Radiat Oncol Biol Phys (2005) 0.91
Time to metabolic atrophy after permanent prostate seed implantation based on magnetic resonance spectroscopic imaging. Int J Radiat Oncol Biol Phys (2004) 0.91
Daily prostate targeting using implanted radiopaque markers. Int J Radiat Oncol Biol Phys (2002) 0.91
Semiquantification and classification of local pulmonary function by V/Q single photon emission computed tomography in patients with non-small cell lung cancer: potential indication for radiotherapy planning. J Thorac Oncol (2011) 0.90
Accounting for center-of-mass target motion using convolution methods in Monte Carlo-based dose calculations of the lung. Med Phys (2004) 0.89
Changes in global function and regional ventilation and perfusion on SPECT during the course of radiotherapy in patients with non-small-cell lung cancer. Int J Radiat Oncol Biol Phys (2011) 0.89
Lhermitte sign after chemo-IMRT of head-and-neck cancer: incidence, doses, and potential mechanisms. Int J Radiat Oncol Biol Phys (2012) 0.88
Evaluating the influence of setup uncertainties on treatment planning for focal liver tumors. Int J Radiat Oncol Biol Phys (2005) 0.87
Evaluating the relationships between rectal normal tissue complication probability and the portion of seminal vesicles included in the clinical target volume in intensity-modulated radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys (2009) 0.86
FusionArc optimization: a hybrid volumetric modulated arc therapy (VMAT) and intensity modulated radiation therapy (IMRT) planning strategy. Med Phys (2013) 0.85
Utility of normal tissue-to-tumor α/β ratio when evaluating isodoses of isoeffective radiation therapy treatment plans. Int J Radiat Oncol Biol Phys (2012) 0.84
Poor baseline pulmonary function may not increase the risk of radiation-induced lung toxicity. Int J Radiat Oncol Biol Phys (2012) 0.82
Predicting outcome of patients with high-grade gliomas after radiotherapy using quantitative analysis of T1-weighted magnetic resonance imaging. Int J Radiat Oncol Biol Phys (2007) 0.82
The influence of beam model differences in the comparison of dose calculation algorithms for lung cancer treatment planning. Phys Med Biol (2005) 0.81
Ideal spatial radiotherapy dose distributions subject to positional uncertainties. Phys Med Biol (2006) 0.81
The impact of breathing motion versus heterogeneity effects in lung cancer treatment planning. Med Phys (2007) 0.81
Effect of normal lung definition on lung dosimetry and lung toxicity prediction in radiation therapy treatment planning. Int J Radiat Oncol Biol Phys (2013) 0.80
A Bayesian mixture model relating dose to critical organs and functional complication in 3D conformal radiation therapy. Biostatistics (2005) 0.80
Response-driven imaging biomarkers for predicting radiation necrosis of the brain. Phys Med Biol (2014) 0.80
Esophagus sparing with IMRT in lung tumor irradiation: an EUD-based optimization technique. Int J Radiat Oncol Biol Phys (2005) 0.79
Predictive models for regional hepatic function based on 99mTc-IDA SPECT and local radiation dose for physiologic adaptive radiation therapy. Int J Radiat Oncol Biol Phys (2013) 0.79
Monte Carlo-based lung cancer treatment planning incorporating PET-defined target volumes. J Appl Clin Med Phys (2005) 0.78
An application of Bayesian statistical methods to adaptive radiotherapy. Phys Med Biol (2005) 0.78
Dosimetric analysis of radiation-induced gastric bleeding. Int J Radiat Oncol Biol Phys (2012) 0.78
Effect of daily localization and correction on the setup uncertainty: dependences on the measurement uncertainty, re-positioning uncertainty and action level. Phys Med Biol (2007) 0.77
Body mass index predicts the incidence of radiation pneumonitis in breast cancer patients. Cancer J (2005) 0.76
Optimizing global liver function in radiation therapy treatment planning. Phys Med Biol (2016) 0.75
Prediction of radiation-induced liver disease by Lyman normal-tissue complication probability model in three-dimensional conformal radiation therapy for primary liver carcinoma: in regards to Xu et al. (Int J Radiat Oncol Biol Phys 2006;65:189-195). Int J Radiat Oncol Biol Phys (2006) 0.75
Reporting and analyzing statistical uncertainties in Monte Carlo-based treatment planning. Int J Radiat Oncol Biol Phys (2006) 0.75
Dosimetric implications of residual seminal vesicle motion in fiducial-guided intensity-modulated radiotherapy for prostate cancer. Med Dosim (2011) 0.75
Designing targets for elective nodal irradiation in lung cancer radiotherapy: a planning study. Int J Radiat Oncol Biol Phys (2008) 0.75
Radiogenomics and radiotherapy response modeling. Phys Med Biol (2017) 0.75